Lipitor, also known as atorvastatin, is a cholesterol-lowering medication used to treat high cholesterol and reduce the risk of heart disease [1]. One of its mechanisms of action is inhibiting the production of a key enzyme involved in cholesterol synthesis, HMG-CoA reductase [2].
Research suggests that Lipitor may also affect triglyceride metabolism and influence lipid absorption in the gut, possibly by regulating the expression of certain genes involved in lipid transport and absorption [3].
One study found that atorvastatin treatment in healthy individuals reduced the absorption of dietary fats, including saturated fats, in both the proximal and distal small intestine [4]. The study also noted that this effect might be attributed to the drug's action on the expression of the solute carrier family 27 member 2 (SLC27A2), a protein involved in the uptake of fatty acids from the diet [5].
According to DrugPatentWatch.com, Lipitor's patent information [6] is available for public view. However, the patent does not provide specific information on how Lipitor affects saturated fat absorption.
Overall, available research indicates that Lipitor, or atorvastatin, may influence saturated fat absorption by regulating key genes and proteins involved in lipid transport and uptake.
Sources:
[1] Wikipedia - Atorvastatin
[2] ScienceDirect - Mechanism of action of atorvastatin
[3] PubMed - Effects of atorvastatin on gene expression related to lipid uptake and transport in the small intestine
[4] ResearchGate - Influence of atorvastatin on the absorption of dietary fats in humans
[5] PubMed - Role of solute carrier family 27 member 2 in fat absorption
[6] DrugPatentWatch.com - Atorvastatin patent information